Novel MHC-Independent αβTCRs Specific for CD48, CD102, and CD155 Self-Proteins and Their Selection in the Thymus
- Front Immunol. 2020 Jun 16:11:1216. doi: 10.3389/fimmu.2020.01216.
- 1. Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Rockville, MD, United States.
- 2. Structural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Rockville, MD, United States.
- 3. Theodor Kocher Institute, Faculty of Bern, Universität Bern, Bern, Switzerland.
- 4. Surgery Branch, National Cancer Institute, National Institutes of Health, Rockville, MD, United States.
MHC-independent αβTCRs (TCRs) recognize conformational epitopes on native self-proteins and arise in mice lacking both MHC and CD4/CD8 coreceptor proteins. Although naturally generated in the thymus, these TCRs resemble re-engineered therapeutic chimeric antigen receptor (CAR) T cells in their specificity for MHC-independent ligands. Here we identify naturally arising MHC-independent TCRs reactive to three native self-proteins (CD48, CD102, and CD155) involved in cell adhesion. We report that naturally arising MHC-independent TCRs require high affinity TCR-ligand engagements in the thymus to signal positive selection and that high affinity positive selection generates a peripheral TCR repertoire with limited diversity and increased self-reactivity. We conclude that the affinity of TCR-ligand engagements required to signal positive selection in the thymus inversely determines the diversity and self-tolerance of the mature TCR repertoire that is selected.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Transmembrane GlycoproteinResearch Areas: Inflammation/Immunology